Your browser doesn't support javascript.
loading
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice.
Kan, Lea Ling-Yu; Chan, Ben Chung-Lap; Yue, Grace Gar-Lee; Li, Peiting; Hon, Sharon Sze-Man; Huang, Danqi; Tsang, Miranda Sin-Man; Lau, Clara Bik-San; Leung, Ping-Chung; Wong, Chun-Kwok.
Affiliation
  • Kan LL; Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chan BC; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.
  • Yue GG; Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Li P; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.
  • Hon SS; Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Huang D; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.
  • Tsang MS; Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Lau CB; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.
  • Leung PC; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Wong CK; Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Chin J Integr Med ; 30(4): 311-321, 2024 Apr.
Article in En | MEDLINE | ID: mdl-37594703

Full text: 1 Database: MEDLINE Main subject: Saline Solution / Neoplasms Language: En Journal: Chin J Integr Med Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Saline Solution / Neoplasms Language: En Journal: Chin J Integr Med Year: 2024 Type: Article Affiliation country: China